(Q48942149)

English

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

scientific article published in June 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo. (English)

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Vaerøy

1

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

A Abrahamsen

2

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

O Førre

3

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

E Kåss

4

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

publication date

1 June 1989

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

Clinical Rheumatology

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

8

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

2

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

245-250

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

Sleep-related myoclonus in rheumatic pain modulation disorder (fibrositis syndrome) and in excessive daytime somnolence.

1 reference

https://api.crossref.org/works/10.1007%2FBF02030081

21 January 2018

Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2667860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2667860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapeutics in fibrositis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2667860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caffeine as an analgesic adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/2667860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/2667860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2667860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02030081

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/2667860

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48942149&oldid=1516251559"